From Guidelines to Real Life—Multidisciplinary Insights for Optimizing Intravesical Bacillus Calmette–Guérin (BCG) Therapy in NMIBC
Oncology and Therapy · 13.11.2026
DOI: 10.1007/s40487-026-00470-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology and Therapy, online erschienen am 13.11.2026. Verfasst von Kathryn Chatterton und 3 weiteren Autor:innen. Beteiligte Einrichtung: Guys and St, Thomas' NHS Foundation Trust, London, UK. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medac.
Abstract (Originalsprache)
Intravesical Bacillus Calmette-Guérin (BCG) therapy remains the mainstay of treatment for high-risk non-muscle-invasive bladder cancer (NMIBC), yet suboptimal adherence and underutilization of maintenance therapy limit real-world outcomes. This commentary summarizes multidisciplinary insights from an expert symposium at the European Association of Urology 2026 meeting, focusing on practical strategies to optimize treatment delivery. Key themes included the critical role of patient education, proactive toxicity management, and consistent multidisciplinary communication in improving adherence to prolonged BCG regimens. Treatment-related adverse events were identified as a major driver for discontinuation, although evidence suggests that true biologic intolerance to BCG is uncommon when best practices are implemented. Substantial clinical evidence indicates that maintenance BCG, rather than induction therapy alone, is necessary to reduce recurrence and progression risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guys and St, Thomas' NHS Foundation Trust, London, UK.
- Department of Urology, University of Texas MD Anderson, Houston, TX, USA.
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- Edinburgh Bladder Cancer Surgery (EBCS), The University of Edinburgh, Western General Hospital, Edinburgh, UK. param.mariappan@nhs.scot.
Förderung
- Medac
Zitieren
APA
Chatterton, K., Kamat, A. M., Lobo, N., & Mariappan, P. (2026). From Guidelines to Real Life—Multidisciplinary Insights for Optimizing Intravesical Bacillus Calmette–Guérin (BCG) Therapy in NMIBC. Oncology and Therapy. https://doi.org/10.1007/s40487-026-00470-7
Vancouver
Chatterton K, Kamat AM, Lobo N, Mariappan P. From Guidelines to Real Life—Multidisciplinary Insights for Optimizing Intravesical Bacillus Calmette–Guérin (BCG) Therapy in NMIBC. Oncology and Therapy. 2026. doi:10.1007/s40487-026-00470-7
BibTeX
@article{Chatterton2026,
author = {Chatterton, Kathryn and Kamat, Ashish M and Lobo, Niyati and Mariappan, Paramananthan},
title = {From Guidelines to Real Life—Multidisciplinary Insights for Optimizing Intravesical Bacillus Calmette–Guérin (BCG) Therapy in NMIBC},
journal = {Oncology and Therapy},
year = {2026},
doi = {10.1007/s40487-026-00470-7}
}
EUVIMED